BTG3 and psoriatic arthritis: The male patient aged between 55 and 60 years diagnosed with spondyloarthritis was identified as having psoriatic arthritis and tested negative for ANA, and is undergoing treatment with sulfasalazine (SSZ) and topical corticosteroid.